By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today announced it has reached a global distribution deal for Almac Group's Xcel array for research use in biomarker discovery targeting diseases such as cancer.

The array is built on Affy's GeneChip Human Genome U133 Plus 2.0 Array platform, optimized for RNA expression profiling from formalin-fixed, paraffin-embedded tissue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.